Clinical data science

The Emerging Role of Artificial Intelligence (AI) in Global Medical Writing

Read our latest blog to understand how MMS is leading the way with AI in medical writing, reducing time, improving quality, and ensuring faster and more reliable drug development processes.

Clinical data science

Press Release

MMS Hires Pharmaceutical Industry Veteran James Zee for Global Biometrics Leadership in Europe Amid Strong Regional Growth

Clinical data science

Good Work Comes From Great Places!

Regulatory Submission

Sponsors Trust MMS With Their Submissions

Our integrated regulatory, writing, publishing, and QC teams have developed effective strategies and led data planning, summarization, and lifecycle management for 50+ marketing applications in the past 5 years.

Functional Service provider FSP

Modern FSP Solutions For An Evolving Industry

Our FSP models are designed to be flexible and scalable, bringing expertise that will increase levels of productivity to align with your organization’s goals.

Decentralized Trial

Together Trial With EDC Database Designed By MMS Wins Trial Of The Year

The TOGETHER Trial, which uses an Electronic Data Capture (EDC) system designed, built, and maintained by MMS Holdings, won the Society for Clinical Trial’s annual Trial of the Year Award.

 global strategies for expedited regulatory approval

A Winning Development Strategy

MMS provides insights into your development plans, including global strategies for expedited regulatory approval and a track record of on-time delivery utilizing our trademarked APP process.

THE DIFFERENCE IS IN THE DATA™

With strong science, robust processes, and a sense of urgency, MMS is redefining the CRO experience. Gain new insights from our data-focused and tech-enabled team of experts. Explore our services:

Regulatory Affairs & Operations

Regulatory Affairs
& Operations

Data Management & Biostatistics

Data Management
& Biostatistics

Regulatory & Medical Writing

Regulatory &
Medical Writing

Drug Safety and pharmacovigilance

Drug Safety &
Pharmacovigilance

Compliance & Transparency

Quality & Compliance 
Services

Transparency Services

Transparency
Services

MMS Light house

Helping sponsors navigate a complex regulatory environment

MMS is an award-winning, data-focused clinical research organization (CRO) that supports the pharmaceutical, biotech, and medical device industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards.

Industry experts across 4 continents are available to support your programs 24×7 with a 97 percent sponsor satisfaction rating

“This team never stopped working towards our deadline, and from day one, we were impressed with the efficient and smart decisions brought forth by MMS to bring this drug to market.” —Randy Brenner, Senior Vice President Global Regulatory Affairs, Quality, and Technical Operations, Paratek
“MMS consistently provides our team with the highest level of detail and quality work in every task that they undertake. I am pleased that we were able to attain this fast track status and look forward to working with MMS as we continue into the phase three studies.” — Dr. Doo Lee, CEO and Head of Research and Development, Vivozon
“The choice in collaborating with MMS to meet this milestone… was simple, given their deep scientific knowledge and strategic resource models,” — Dr. Steven Gullans, CEO, Gemphire

Latest News

MAPS has submitted an NDA to the FDA for the first PTSD psychedelic therapy with MMS support.

 Together Trial with EDC Database Designed by MMS Wins Trial of the Year MAPS PBC selected MMS as its CRO partner for the development of NDA for MDMA-assisted therapy for PTSD. If approved, MDMA-assisted therapy could be the first psychedelic-assisted therapy.

Latest Webinar

View To Our Latest Webinar on Training That Transforms: A Quality Approach

 How to Submit Non-Clinical Data to CBER Using SENDIn an era where knowledge is power, the ability to effectively train and develop your team sets the leaders apart from the followers. “Training That Transforms: A Quality Approach” is more than a webinar; it’s a stepping stone to excellence in your educational initiatives.

Featured Blog

The Silent Battle: Exploring PTSD Treatments and Psychedelic Research in Veteran Care

 EMA Revised Transparency Rules Eliminate the Deferral Mechanism for Clinical Trial Data PublicationExplore PTSD treatments, psychedelic research, and MMS’ role in veteran care. Gain insights from combat medic Ritchie Patton, MMS’ regulatory expert. Connect for deeper insights.

Featured Sponsor

MMS Partners with I-ACT to Advance Children’s Clinical Trials

  Novel PTSD Treatment Advances Toward Regulatory Evaluation with New Collaboration Between MAPS PBC and MMS HoldingsMMS collaborates with I-ACT to accelerate pediatric clinical trials, supporting life-saving therapies for children. Learn more about the Spin Challenge and our commitment to advancing pediatric drug development.